Sanity Group comments on GKV law on cannabis
The law removes medical cannabis flowers from GKV reimbursement and gives finished medicinal products six months priority.
See the latest news and media coverage for Sanity Group. We track all announcements, press releases, and industry mentions in real time, all in one place.
European medical cannabis company
sanitygroup.comLast updated
In short: Sanity Group was acquired by Canada's Organigram for up to €250 million, creating a vertically integrated leader in the European market.
The law removes medical cannabis flowers from GKV reimbursement and gives finished medicinal products six months priority.
The transaction values Sanity Group at up to €250 million. Both companies aim to accelerate growth in Europe. Sanity continues operations with its team and brands.
The merger integrates Sanity's European platform with Organigram's production and innovation expertise, creating a vertically integrated value chain from cultivation to patient access.
EKOCAN interim report shows stable consumption, declining adolescent use, and shift to legal sources. Company warns against hasty amendments and pushes for pilot retail projects.
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform following...
Organigram Global Inc. (NASDAQ:OGI) is one of the 10 best tobacco and cigarette stocks to invest in. On April 15, Organigram Global Inc. (NASDAQ:OGI) finalized...
BT DE Investments, a British American Tobacco affiliate, now owns 29.9% of Organigram’s Common Shares plus all Preferred Shares following the Sanity Group deal and...
Detailed price information for Organigram Global Inc (OGI-Q) from The Globe and Mail including charting and trades.
Track Sanity Group and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Sanity Group and other trending companies.